NEW YORK (GenomeWeb News) – Molecular diagnostics is gaining traction among clinicians and were the second-most popular type of test performed in the second quarter, according to a survey released today by investment bank Mizuho Securities.

In the survey of 262 physicians and laboratory personnel for clues about trends in clinical labs, Mizuho found that molecular testing made up 25 percent of all tests performed during the second quarter of this year, trailing only immunochemical tests, which made up 36 percent of all test conducted.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: swapping yeast genes with human orthologs to study conservation of function, and more.

Hong Kong is using DNA phenotyping to shame litterers.

A study appearing in Cell suggests some metastatic castration-resistant prostate cancer patients could benefit from PARP inhibitor therapy.

NIH's Francis Collins writes that scientific advances are poised to help populations all over the world, but more scientists are needed to keep the momentum.